Xyntha (Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Xyntha drug offered from Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
NON-PROPRIETARY NAME: | antihemophilic factor (recombinant) |
SUBSTANCE NAME: | |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
Xyntha PLASMA DERIVATIVE Details:
Item Description | Xyntha from Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
LABELER NAME: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2008-08-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58394-012_72acb4c2-2341-4297-926e-f03c01a4a379 |
PRODUCT NDC: | 58394-012 |
APPLICATION NUMBER: | BLA125264 |